First-line PARP inhibitors (PARPi) with androgen receptor pathway inhibitors (ARPi) in metastatic castration-resistant prostate cancer (mCRPC): A systematic review and meta-analysis.
| Autor: | Khan, Muhammad Ali, Naqvi, Syed Arsalan Ahmed, Imran, Manal, Channar, Aneeta, Saxena, Akshat, Raina, Ammad, Khakwani, Kaneez Zahra Rubab, Riaz, Zaryab Bin, Kase, Adam McLain, Humphreys, Mitchell R., Moore, Cassandra N., Orme, Jacob, Childs, Daniel S, Singh, Parminder, Bryce, Alan Haruo, Palmer, Jeanne M., Riaz, Irbaz Bin |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p173-173, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|